Bruker Corporation BRKR
Set alert
57.37 USD +1.68 +3.02%
As of Nov 3, 9:32 AM ET
55.80 Day range 57.56
32.37 52-week range 66.98
- YTD
- +21.78%
- 1 year
- +47.33%
- Open
- 57.07
- Prev close
- 55.69
- Mkt cap
- 8.75B
- Vol
- 36.78K
- Avg vol
- 2.29M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.32%
More statistics
- Low
- 55.80
- High
- 57.56
- Forward P/E
- 23.17
- Beta
- 1.27
- Short ratio
- 5.27
- Inst. own
- 95.54%
- Dividend
- 0.20
- Ex-div date
- Sep 20, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 58.90
- 200-d avg
- 50.22
- 1y target
- 63.83
5Y chart
Events in this range
- Nov 30, 2021Dividend: 0.04
- Feb 28, 2022Dividend: 0.05
- May 31, 2022Dividend: 0.05
- Aug 31, 2022Dividend: 0.05
- Sep 1, 2022Dividend: 0.05
- Nov 30, 2022Dividend: 0.05
- Dec 16, 2022Dividend: 0.05
- Feb 28, 2023Dividend: 0.05
- May 31, 2023Dividend: 0.05
- Aug 31, 2023Dividend: 0.05
- Nov 30, 2023Dividend: 0.05
- Feb 29, 2024Dividend: 0.05
- May 31, 2024Dividend: 0.05
- Jun 3, 2024Dividend: 0.05
- Aug 30, 2024Dividend: 0.05
- Dec 2, 2024Dividend: 0.05
- Mar 17, 2025Dividend: 0.05
- Jun 16, 2025Dividend: 0.05
- Aug 4, 2025Earnings: 0.32; estimate 0.33; surprise -3.03%
- Sep 23, 2025Dividend: 0.05
- Nov 3, 2025Earnings: 0.6; estimate 0.33; surprise 81.82%
- Dec 8, 2025Dividend: 0.05
- Feb 12, 2026Earnings: 0.59; estimate 0.65; surprise -9.23%
- Mar 23, 2026Dividend: 0.05
- May 6, 2026Earnings: 0.31; estimate 0.23; surprise 34.78%
- Jun 22, 2026Dividend: 0.05
- Aug 4, 2026Earnings: 0.49; estimate 0.3849; surprise 27.31%
- Sep 9, 2026Rating: UBS · Neutral → Neutral
- Sep 21, 2026Dividend: 0.05
- Sep 29, 2026Rating: Leerink Partners · Outperform → Outperform
- Oct 1, 2026Rating: Guggenheim · Buy → Buy
- Oct 7, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: TD Cowen · Hold → Hold
- Oct 14, 2026Downgrade: JP Morgan · Overweight → Neutral
- Nov 4, 2026Earnings: —; estimate 0.4191; surprise —%
Signals (77)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 1, 2025 | 1 year ago |
Newest 20 of 77.
Analyst view
Consensus: buy
Buy
Price target (mean) 63.83 +11.3% upside
Now 57.37
- Target (low)
- 50.00
- Target (mean)
- 63.83
- Target (high)
- 80.00
Ratings (0m) 13 6 buy · 6 hold · 1 sell
- Strong buy1
- Buy5
- Hold6
- Sell1
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.41601 | 0.39 – 0.44849 | 0.45 | -7.6% | 865.19M | +0.5% | 12 |
| Next quarter | 0.90212 | 0.87 – 0.91289 | 0.59 | +52.9% | 1.03B | +5.1% | 12 |
| Current year | 2.12 | 2.10 – 2.14 | 1.83 | +15.8% | 3.56B | +3.5% | 13 |
| Next year | 2.40 | 2.28 – 2.47 | 2.12 | +13.4% | 3.70B | +4.2% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 7, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 7, 2026 | UBS | Maintained | Neutral | Neutral |
| May 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| May 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 15, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 13, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 13, 2026 | Goldman Sachs | Maintained | Sell | Sell |
| Feb 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Feb 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 16, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jan 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| Jan 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 15, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 15, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Dec 15, 2025 | Wells Fargo | Maintained | Overweight | Overweight |